Similarly, the most senior R&D folks in R&D driven companies get the idea immediately. But what about tech transfer offices, most lawyers at IP law firms, assorted academic experts in innovation, and university administrators? You can guess. 2/2
In my experience, the most sophisticated lawyers who deal with IP strategy are the most senior internal counsels at multinational companies. It takes a few milliseconds to explain our
#openscience partnership principles and to get them to endorse them. 1/
I suspect, all in, there is no science, educational, or business case supporting university patenting, and a far better case to explore different ways to translate our ideas into impact and products. 4/4.
And factor in the opportunity costs. The money spent on tech transfer. The time wasted on MTA’s and IP negotiations. The students who are not allowed to talk about their work. The ways in which the knowledge/innovation tree may be pruned, and the less fortunate are excluded. 3/
Not allowed using non-evidence assumptions or anecdotes like: “industry won’t work with universities without patents” or “there was no way this idea would have advanced if there was no IP”. 2/
I challenge policy wonks to do a “life cycle analysis” and provide compelling evidence (sans anecdote, with no non evidence-based assumptions) that patenting by universities is net positive for institutions, for science, or for society. I don’t think it’s possible. 1/
Pundits on @cbcsports finding the positives about @MapleLeafs before game 2 of their playoff series tonight. “They have a lot of experience being down 1-0”.
RT @northernthrux
Loads of career advancement possibilities as our 6 year, $24M New Frontiers in Research Fund-Transformation award that builds on the @Brains_CAN initiative takes flight. And you get to work with nice people. Come take a look!!
https://twitter.com/GervNiki/status/1654183505905975296
Nicole Gervais on Twitter
“🚨Amazing job alert🚨 Research Project Manager position available @Brains_CAN asap. Work with ourstanding scientists including: @maximoprado @mallarchkrvrty1. Lots of career advancement opportunities. Apply by May 16 here: https://t.co/t2qsv150JA (Job ID: 30828) @HBHLMcGill”
TwitterA summary of this review paper on autoimmunity:
1. There are hundreds of genetic contributions
2. Very few have functional explanation
3. This is a big problem
4. Let's help by creating high-quality reagents for all the proteins (OK, that one was mine)
https://www.science.org/doi/10.1126/science.adg2992RT @countthedead
A Paper That Says Science Should Be Impartial Was Rejected From Major Journals. You Can’t Make This Up.
https://www.nytimes.com/2023/05/04/opinion/science-evidence-merits.html?smid=tw-share
Opinion | A Paper That Says Science Should Be Impartial Was Rejected by Major Journals. You Can’t Make This Up.
Research ought to be independent, not ideological.
The New York Times